HAEMONETICS CORP Insider Trading for August 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HAEMONETICS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in HAEMONETICS CORP for August 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 25 2016 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 29.72 | 11,758 | 349,448 | 0 | |
Aug 25 2016 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 29.72 | 11,758 | 349,448 | 66,985 | 55.2 K to 67 K (+21.29 %) |
Aug 25 2016 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Payment of Exercise | F | 30.09 | 11,614 | 349,465 | 55,371 | 67 K to 55.4 K (-17.34 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.22 | 10 | 352 | 17,851 | 17.9 K to 17.9 K (-0.06 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.21 | 300 | 10,563 | 17,861 | 18.2 K to 17.9 K (-1.65 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.21 | 130 | 4,577 | 18,161 | 18.3 K to 18.2 K (-0.71 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.20 | 100 | 3,520 | 18,291 | 18.4 K to 18.3 K (-0.54 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.17 | 110 | 3,869 | 18,391 | 18.5 K to 18.4 K (-0.59 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.17 | 200 | 7,033 | 18,501 | 18.7 K to 18.5 K (-1.07 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.16 | 100 | 3,516 | 18,701 | 18.8 K to 18.7 K (-0.53 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.13 | 2,500 | 87,825 | 18,801 | 21.3 K to 18.8 K (-11.74 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.13 | 200 | 7,025 | 21,301 | 21.5 K to 21.3 K (-0.93 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.12 | 187 | 6,567 | 21,501 | 21.7 K to 21.5 K (-0.86 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.12 | 100 | 3,512 | 21,688 | 21.8 K to 21.7 K (-0.46 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.11 | 100 | 3,511 | 21,788 | 21.9 K to 21.8 K (-0.46 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.11 | 100 | 3,511 | 21,888 | 22 K to 21.9 K (-0.45 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.10 | 100 | 3,510 | 21,988 | 22.1 K to 22 K (-0.45 %) |
Aug 19 2016 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 35.09 | 100 | 3,509 | 22,088 | 22.2 K to 22.1 K (-0.45 %) |
Aug 18 2016 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Option Exercise | A | 35.00 | 57,149 | 1,999,981 | 57,149 | |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | M | 27.24 | 8,580 | 233,719 | 0 | |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | M | 27.24 | 8,580 | 233,719 | 0 | |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.32 | 100 | 3,532 | 22,316 | 22.4 K to 22.3 K (-0.45 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.32 | 100 | 3,532 | 22,316 | 22.4 K to 22.3 K (-0.45 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.33 | 200 | 7,066 | 22,116 | 22.3 K to 22.1 K (-0.90 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.33 | 200 | 7,066 | 22,116 | 22.3 K to 22.1 K (-0.90 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.34 | 300 | 10,602 | 21,816 | 22.1 K to 21.8 K (-1.36 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.34 | 300 | 10,602 | 21,816 | 22.1 K to 21.8 K (-1.36 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.35 | 200 | 7,069 | 21,616 | 21.8 K to 21.6 K (-0.92 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.35 | 200 | 7,069 | 21,616 | 21.8 K to 21.6 K (-0.92 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.35 | 5,305 | 187,532 | 16,311 | 21.6 K to 16.3 K (-24.54 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.35 | 5,305 | 187,532 | 16,311 | 21.6 K to 16.3 K (-24.54 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Buy | M | 27.24 | 8,580 | 233,719 | 24,891 | 16.3 K to 24.9 K (+52.60 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Buy | M | 27.24 | 8,580 | 233,719 | 24,891 | 16.3 K to 24.9 K (+52.60 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.35 | 8,280 | 292,698 | 16,611 | 24.9 K to 16.6 K (-33.27 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.35 | 8,280 | 292,698 | 16,611 | 24.9 K to 16.6 K (-33.27 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.36 | 300 | 10,607 | 16,311 | 16.6 K to 16.3 K (-1.81 %) |
Aug 16 2016 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 35.36 | 300 | 10,607 | 16,311 | 16.6 K to 16.3 K (-1.81 %) |
Aug 08 2016 | HAE | HAEMONETICS CORP | Simon, Christopher | President & CEO | Buy | P | 35.00 | 60,000 | 2,099,754 | 105,867 | 45.9 K to 105.9 K (+130.81 %) |